Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

SciSparc Sets Up $10 Million Convertible Note Facility With Warrants

Tipranks - Fri Feb 13, 3:30PM CST

Valentine's Day Sale - 70% Off

An update from SciSparc Ltd. ( (SPRC) ) is now available.

On February 12, 2026, SciSparc Ltd. entered into a Securities Purchase Agreement with an institutional investor allowing the company to issue up to $10 million in convertible promissory notes, starting with an initial $2.5 million note sold at a 10% discount. Alongside each note, SciSparc issues matching three-year warrants equal to 100% warrant coverage for the maximum conversion shares, with the proceeds earmarked for working capital and general corporate purposes.

Beginning April 1, 2026, SciSparc may, at its discretion, request additional $2.5 million tranches every three months, up to the $10 million cap, without minimum draw requirements or operational restrictions. The notes bear 4% annual interest, are repayable over ten monthly installments starting 18 months after issuance, and are convertible into ordinary shares at a formula-based price with a floor, implying potential future equity dilution and expanded trading float once resale registration is effective.

More about SciSparc Ltd.

SciSparc Ltd. is an Israel-based company whose ordinary shares trade on the Nasdaq Capital Market. It operates as a foreign private issuer under U.S. securities laws and uses capital markets financing to support its working capital and general corporate purposes.

Average Trading Volume: 2,177,232

Technical Sentiment Signal: Sell

Current Market Cap: $2.88M

Find detailed analytics on SPRC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.